Isabelita Vengco

MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy

Linda Moy, L. Moy, S. Adams, 2014, Journal of Immunotherapy for Cancer.

Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma

S. Adams, L. Chiriboga, P. Ott, 2015, Cancer Immunology Research.

Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis

J. Ohlfest, Z. Xiong, Wei Chen, 2008, Clinical Cancer Research.

Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma

Wei Chen, W. Low, J. Ohlfest, 2007, Cancer Gene Therapy.

Phase I/II study of resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma.

S. Adams, L. Chiriboga, P. Ott, 2012 .

Preparation of tumor antigen-loaded mature dendritic cells for immunotherapy.

N. Bhardwaj, Elizabeth A. Miller, Meredith R. Spadaccia, 2013, Journal of visualized experiments : JoVE.

Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma.

D. Largaespada, S. Ekker, W. Low, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma

S. Adams, L. Chiriboga, P. Ott, 2015, Cancer Immunology Research.

PD-1 Is Elevated on the Peripheral Blood T Cell Subsets of Patients with Relapsed/Refractory Hodgkin Lymphoma Compared to Normal Volunteers

O. O’Connor, C. Diefenbach, J. Zain, 2011 .